Xencor | XNCR - Market Capitalization


Xencor reported $1.21B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 209.65B 14.21B Aug/2026
Arrowhead Research USD 11.15B 2.37B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Cytokinetics USD 9.6B 1.95B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 143.89B 5.44B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Xencor USD 1.21B 19M Aug/2026